Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

204.89 USD UNCHANGED
Streaming Delayed Price Updated: 7:56 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Eli Lilly

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Cramer warns pharma still not safe to own despite Trump’s softened stance
Jim Cramer expected Donald Trump to walk into his meeting with pharma executives with a baseball bat. Instead, he jawboned them. 
Tags Biotechnology Health Care/Pharmaceuticals Biotechnology and Life Sciences Investing/Indexes/S&P 500
From CNBC.com News
People Aren't Buying Highs; They Are Buying Dips
U.S. equities slide for a fourth consecutive session on mixed earnings although stocks pared losses to end the day nearly unchanged. 
Tags Stocks / Equities Technology Healthcare
From Blogs - TalkMarkets
UPDATE 4-Trump pushes drugmakers for lower prices, more U.S. production
WASHINGTON/LOS ANGELES, Jan 31 (Reuters) - U.S. President Donald Trump in a meeting on Tuesday with pharmaceutical executives called on them to manufacture more of their drugs in the United States and... 
Tags companyNews
From Reuters: Company News
Lilly Posts Mixed Q4, But Stock Gets A Trump Bump
Lilly stock rose as Q4 sales easily beat and President Trump's pledge to ease drug regulations overshadowed an EPS miss. 
Tags Technology
From Investor's Business Daily
BRIEF-Lilly CEO says prepared for all scenarios in case of ACA repeal
* Lilly CEO says if all Alimta patents are upheld, drug will be exclusively marketed in the U.S. till 2022 
Tags companyNews
From Reuters: Company News
UPDATE 3-Trump pushes drugmakers for lower prices, more U.S. production
WASHINGTON/LOS ANGELES, Jan 31 (Reuters) - U.S. President Donald Trump on Tuesday met with top executives from some of the biggest drugmakers, calling on them to boost U.S. production and lower prices,... 
Tags companyNews
From Reuters: Company News
President Trump says he wants to bring down drug prices. His example? Aspirin
The widely-available pain reliever costs less than a cent per pill. 
Tags Health/Care Medical Products Pharmaceuticals
From MarketWatch
Pfizer Reports Lagging Q4 EPS; Rebounds On Trump Commentary
Pfizer stock regained earlier losses Tuesday after reporting Q4 earnings that lagged, though quarterly and full-year revenue were in line. 
Tags Technology
From Investor's Business Daily
President Trump Doubles Down On Healthcare Criticism, Says Drug Prices Are 'Astronomical'
President Donald Trump said Tuesday that drug prices are "astronomical" and much needed change needs to be implemented. His ... 
Tags LABU Donald Trump NVS
From Benzinga
Eli Lilly and Co (LLY) Gains on Earnings Announcement
Eli Lilly and Co (NYSE: LLY) shares hiked 1.7% to $75.97, as the company was expected to report quarterly earnings at $0.97 per share on revenue of $5.54 billion. Share volume was 1.2 million, compared... 
From Baystreet.ca RSS Feed
Celgene, Lilly, Merck Sit With Trump On His Calls To Manufacture In U.S.
President Trump called for drugmakers to manufacture in the U.S. in an effort to curb rising prices, during a meeting at the White House. 
Tags Technology
From Investor's Business Daily
Fed Meeting Starts Today, But Focus Remains On Key Earnings Data
On a day when the Fed’s latest meeting begins, focus may end up being several thousand miles further west. The Fed meeting ... 
Tags The Ticker Tape Earnings LLY
From Benzinga
Trump meets with drugmakers, seeks lower prices, U.S. production
WASHINGTON, Jan 31 (Reuters) - U.S. President Donald Trump, in a meeting with the chief executives of several top drugmakers on Tuesday, called on the pharmaceutical industry to boost their U.S.... 
Tags companyNews
From Reuters: Company News
Pfizer Inc. Shares Fall On Earnings Miss, Eli Lilly And Co. Little Changed On Sales Beat
Pfizer reported GAAP earnings of 13 cents per share, swinging from a loss of 3 cents per share in the year-ago quarter. Innovative Health revenues rose 1% to $7.7 billion, while Essential Health sales... 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
The Market In 5 Minutes: Under Armour's Miss, Apple's Q1 Primer
Macro Focus Futures for the Dow Jones Industrial Average tumbled 25 points to 19,863.00, while the Standard & Poor’s ... 
Tags PFE Top Stories SPY
From Benzinga
Healthcare Q4: Eli Lilly Beats, Pfizer Misses
Healthcare stocks were under pressure Tuesday morning after two notable industry titans, Pfizer Inc. (NYSE: PFE) and Eli Lilly and Co ... 
Tags Guidance News Health Care
From Benzinga
Early movers: UAA, XOM, UPS, MA, LLY, HOG, PFE & more
These are the stocks posting the largest moves before the bell. 
Tags AmerisourceBergen Business/Earnings Coach Inc
From CNBC.com News
A Peek Into The Markets: U.S. Stock Futures Down; Apple Earnings In Focus
Pre-open movers U.S. stock futures traded lower in early pre-market trade. Mastercard Inc (NYSE: MA) is set to report earnings ... 
Tags U/S/ stock futures A Peek Into The Markets Eurozone
From Benzinga
BRIEF-Lilly reports Q4 EPS $0.73
* Q4 earnings per share view $0.98 -- Thomson Reuters I/B/E/S 
Tags companyNews
From Reuters: Company News
UPDATE 1-Lilly revenue beats as diabetes drug sales rise
Jan 31 (Reuters) - Eli Lilly and Co reported better-than-expected quarterly revenue, lifted by higher demand for its diabetes drugs Trulicity and Humalog. 
Tags companyNews
From Reuters: Company News
Lilly revenue rises 7.2 pct on higher demand for new drugs
Jan 31 (Reuters) - Eli Lilly and Co reported a 7.2 percent rise in quarterly revenue, lifted by higher demand for its diabetes drug Trulicity and other new treatments. 
Tags companyNews
From Reuters: Company News
BRIEF-Jaguar Animal Health, Elanco US to license, develop, and commercialize Canalevia
* Jaguar Animal Health - co and Elanco US enter agreement to license, develop, and commercialize Canalevia Source text for Eikon: Further company coverage: 
Tags companyNews
From Reuters: Company News
15 Stocks You Should Be Watching Today
Some of the stocks that may grab investor focus today are: Wall Street expects Eli Lilly and Co (NYSE: LLY) to report ... 
Tags Benzinga MA XOM
From Benzinga
Earnings Scheduled For January 31, 2017
Companies Reporting Before The Bell Coach Inc (NYSE: COH) is projected to report its quarterly earnings at $0.75 per share on ... 
Tags MAN ZBH Pre/Market Outlook
From Benzinga
Futures point to lower open on Wall Street; Trump immigration controversy; earnings
U.S. stocks pointed to a lower open on Tuesday as traders continued to digest President Trump's controversial refugee policy and eyed a deluge of earnings. 
Tags S&P 500 Fut (Mar'17) Politics and Government/International Organizations/OPEC NASDAQ 100 Fut (Mar'17)
From CNBC.com News
Jaguar Animal Health, Elanco Announce Global Collaboration for Development, Co-Promotion of Canalevia; Jaguar to Receive Upfront Payment of $1.5M
Jaguar Animal Health, Inc. (NASDAQ: JAGX) and Elanco US Inc., a subsidiary of Eli Lilly and Company (NYSE: LLY), today announced an ... 
Tags JAGX News Benzinga
From Benzinga
PRESS DIGEST- New York Times business news - Jan 31
Jan 31 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. 
Tags companyNews
From Reuters: Company News
UPDATE 1-Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit
NEW YORK, Jan 30 (Reuters) - Three of the biggest makers of diabetes treatments, Sanofi SA, Novo Nordisk and Eli Lilly & Co, were named in a class action lawsuit about price fixing filed by a group of... 
Tags companyNews
From Reuters: Company News
Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit
NEW YORK, Jan 30 (Reuters) - Three of the biggest makers of diabetes treatments, Sanofi SA, Novo Nordisk and Eli Lilly & Co, were named in a class action lawsuit about price fixing filed by a group of... 
Tags companyNews
From Reuters: Company News
Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In Alzheimer's Where Competitors Fail
Alzheimer's has proven to be one of the most stubborn diseases known to modern medicine. An incurable, devastating illness that ... 
Tags Aducanumab Health Care solanezumab
From Benzinga
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.